treatment of corneal lesions in individuals with vernal keratoconjunctivitis
Clicks: 251
ID: 156576
2005
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
251 views
20 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #52 of 108 articles by views in current drug discovery technologies
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Vernal keratoconjunctivitis, a severe form of allergic conjunctival disease, is characterized by the development of various types of corneal lesions in conjunction with proliferative changes in the conjunctiva. Expression of bioactive substances, such as chemokines and adhesion molecules, by corneal fibroblasts likely contribute to the formation of corneal lesions by promoting local infiltration, activation, and survival of immune cells. Proliferation and deposition of extracellular matrix by conjunctival fibroblasts also may provide conditions which support the activation and survival of immune cells. Topical administration of corticosteroids is the principal mode of treatment for conjunctival inflammation in individuals with vernal keratoconjunctivitis. In some individuals, however, the surgical removal of conjunctival giant papillae or of corneal plaques is indicated.
| Reference Key |
kumagai2005allergologytreatment
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Naoki Kumagai;Ken Fukuda;Youichiro Fujitsu;Keisuke Seki;Teruo Nishida |
| Journal | current drug discovery technologies |
| Year | 2005 |
| DOI |
10.2332/allergolint.54.51
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.